EraGen Antes Up in Anthrax-Detection Market With Own DNA-Based Product | GenomeWeb

NEW YORK, Nov. 7 - EraGen Biosciences on Wednesday threw its hat into the anthrax-detecting ring by announcing that it has developed a test that can detect the bacterium more rapidly than currently available tests.

The test, which is based on the company’s AEGIS technology, may help physicians reduce the time to detect the Bacillus anthracis “from days to hours,” EraGen said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.